What amount sold does Novilytic, LLC report in Form D filings?

The latest linked filings report $1.5M sold across 2 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Novilytic, LLC's most recent SEC filing?

Novilytic, LLC's most recent Form D filing was on 2025-12-15.

How many investors does Novilytic, LLC have?

The most recent Form D filing lists 8 investor(s).

Novilytic, LLC

CIK: 0001850261·Biotechnology·WEST LAFAYETTE, IN

Reported Sold

$1,480,800

Total Filings

Identified Offerings

Last Filed

Dec 15, 2025

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

Offering filing timeline

Dec 15, 2025Form D — New notice

Reported sold: $530,800 · Target: $1,000,000

Rule 506(b)·8 investors

Apr 13, 2021Form D — New notice

Reported sold: $950,000 · Target: $3,000,000

Rule 506(b)·7 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

$1 - $1,000,000

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 2 identified offerings

$1,480,800

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Paul C Dreier

Executive Officer, Director, Promoter

Appears on 1 filing

Jonathan Edwardsen

Director

Appears on 1 filing

Johnston Erwin

Director

Appears on 1 filing

Fred E Regnier

Executive Officer, Director

Appears on 1 filing

Alan Symons

Director

Appears on 1 filing

Edward W Woenker

Director

Appears on 1 filing

Timothy E Woenker

Director

Appears on 1 filing

Rich Wynne

Executive Officer

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Dec 15, 2025	New	$1,000,000	$530,800	8
Apr 13, 2021	New	$3,000,000	$950,000	7

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

PAHTIA TECHNOLOGIES INC

Biotechnology

Offering target: $500,000

Filed Sep 17, 2026